NOVN
$0.51
Novan
$.00
.57%
NOVN
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.05)
Revenue:  $1.24 Mil
Tuesday
Nov 10
0:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when NOVN reports earnings?
Beat
Meet
Miss

Where is NOVN's stock price going from here?
Up
Flat
Down
Stock chart of NOVN
Analysts
Summary of analysts' recommendations for NOVN
Score
Grade
Pivots
Resistance
$0.57
$0.55
$0.53

$0.52

Support
$0.50
$0.48
$0.46
Tweet
Growth
Description
Novan, Inc. is a pharmaceutical company. It engaged in the development and commercialization of therapies using its nitric oxide platform for dermatology. The Company's product candidates primarily include SB204, SB206, SB208 and SB414 which are in pre-clinical trial stage. It develops product through Nitricil technology(TM). Novan, Inc. is based in Durham, United States.